In familial Mediterranean fever, soluble TREM-1 plasma level is higher in case of amyloidosis
Innate Immunity · 2019-11 · 25 (8) · 487-490
DOI: 10.1177/1753425919870847 ↗Kurz gefasst
Fachartikel in der Zeitschrift Innate Immunity, online erschienen am 31.08.2019. Verfasst von Clémence Gorlier und 10 weiteren Autor:innen. Beteiligte Einrichtung: Rheumatology Department, Assistance Publique - Hôpitaux de Paris (AP-HP), Saint-Antoine Hospital, France. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
We aimed to explore triggering receptor expressed on myeloid cells-1 (TREM-1) activation in familial Mediterranean fever (FMF), the most frequent monogenic auto-inflammatory disease, through the measurement of its serum soluble form, named sTREM-1. Blood samples from patients with FMF according to Livneh criteria followed in the French FMF national center and carrying two pathogenic MEFV mutations were collected. Serum level of sTREM-1 was assessed using ELISA. Demographic data, presence of FMF attack, association with histologically proven AA amyloidosis, and blood levels of C-reactive protein (CRP), serum amyloid A (SAA) protein, and creatinine were collected. TREM-1 was available in 56 patients (33.9% male, mean age 43 yr); AA amyloidosis was associated in six patients (19.6% in FMF). Mean sTREM-1 level did not differ significantly between patients having an attack or not and there was also no significant correlation between the level of sTREM-1 and CRP and SAA protein. However, the mean rate of sTREM-1 was significantly higher among FMF patients with AA amyloidosis versus without, though the concomitant SAA protein level was normal. Serum level of sTREM-1 was higher in patients with amyloidosis even though the concomitant SAA protein level was normal. sTREM-1 plasma levels could be an accurate tool to specifically identify FMF patients with amyloidosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Rheumatology Department, Assistance Publique - Hôpitaux de Paris (AP-HP), Saint-Antoine Hospital, France.
- Inserm U970, Paris Cardiovascular Research Center, Université René Descartes, France.
- Plateforme de Recherche Clinique de l'Est Parisien (URCEST-CRCEST-CRB), AP-HP, Saint-Antoine Hospital, France.
- Département de Génétique médicale, AP-HP, Hôpital Trousseau, Paris, France.
- Département de Biochimie, AP-HP, Hôpital Tenon, Paris, France.
- Centre de référence des maladies auto-inflammatoires et des amyloses d'origine inflammatoire (CEREMAIA), AP-HP, Hôpital Tenon, Paris, France.
ORCID-Profile: Clémence Gorlier
Zitieren
APA
Gorlier, C., Sellam, J., Laurans, L., Simon, T., Giurgea, I., Bastard, J. P., Fellahi, S., Deshayes, S., Grateau, G., Ait Oufella, H., & Georgin-Lavialle, S. (2019). In familial Mediterranean fever, soluble TREM-1 plasma level is higher in case of amyloidosis. Innate Immunity, 25(8), 487-490. https://doi.org/10.1177/1753425919870847
Vancouver
Gorlier C, Sellam J, Laurans L, Simon T, Giurgea I, Bastard JP, et al. In familial Mediterranean fever, soluble TREM-1 plasma level is higher in case of amyloidosis. Innate Immunity. 2019;25(8):487-490. doi:10.1177/1753425919870847
BibTeX
@article{Gorlier2019,
author = {Gorlier, Clémence and Sellam, Jérémie and Laurans, Ludivine and Simon, Tabassome and Giurgea, Irina and Bastard, Jean-Philippe and Fellahi, Soraya and Deshayes, Samuel and Grateau, Gilles and Ait Oufella, Hafid and Georgin-Lavialle, Sophie},
title = {In familial Mediterranean fever, soluble TREM-1 plasma level is higher in case of amyloidosis},
journal = {Innate Immunity},
year = {2019},
volume = {25},
number = {8},
pages = {487--490},
doi = {10.1177/1753425919870847}
}
EUVIMED